Road Traffic Noise and Incidence of Primary Hypertension: A Prospective Analysis in UK Biobank.
Background
The quality of evidence regarding the associations between road traffic noise and hypertension is low due to the limitations of cross-sectional study design, and the role of air pollution remains to be further clarified.
Objectives
The purpose of this study was to evaluate the associations of long-term road traffic noise exposure with incident primary hypertension; we conducted a prospective population-based analysis in UK Biobank.
Methods
Road traffic noise was estimated at baseline residential address using the common noise assessment method model. Incident hypertension was ascertained through linkage with medical records. Cox proportional hazard models were used to estimate hazard ratios (HRs) for association in an analytical sample size of over 240,000 participants free of hypertension at baseline, adjusting for covariates determined via directed acyclic graph.
Results
During a median of 8.1 years follow-up, 21,140 incident primary hypertension (International Classification of Diseases-10th Revision [ICD-10]: I10) were ascertained. The HR for a 10 dB[A] increment in mean weighted average 24-hour road traffic noise level (Lden) exposure was 1.07 (95% CI: 1.02-1.13). A dose-response relationship was found, with HR of 1.13 (95% CI: 1.03-1.25) for Lden >65 dB[A] vs ≤55 dB[A] (P for trend <0.05). The associations were all robust to adjustment for fine particles (PM2.5) and nitrogen dioxide (NO2). Furthermore, high exposure to both road traffic noise and air pollution was associated with the highest hypertension risk.
Conclusions
Long-term exposure to road traffic noise was associated with increased incidence of primary hypertension, and the effect estimates were stronger in presence of higher air pollution.
Funding
GCRF: Building capacity for the future city in developing countries (PEAK)
Department for Business, Energy and Industrial Strategy
Find out more...State Scholarship Fund of China Scholarship Council (grant no: 202006015008)
National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Oxford Martin school (OMS), University of Oxford
Investigating the stratified efficacy and safety of pharmacological blood pressure lowering: individual patient-level data meta-analyses of over 300,000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration
British Heart Foundation
Find out more...National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Environmental Exposures and Health at the University of Leicester development award, a partnership between the UK Health Security Agency, the Health and Safety Executive and the University of Leicester
History
Author affiliation
National Institute for Health Research Health Protection Research Unit in Environmental Exposures and Health at the University of LeicesterVersion
- VoR (Version of Record)